Quotes 5-day view Delayed Nyse
10/26/2020
10/27/2020
10/28/2020
10/29/2020
10/30/2020
Date
37.92(c)
37.43(c)
35.45(c)
35.28(c)
35.48(c)
Last
32 052 303
34 963 528
32 122 867
26 134 103
24 140 812
Volume
-0.68% -1.29% -5.29% -0.48% +0.57% Change
Sales 2020
48 968 M - -
Net income 2020
13 308 M - -
Net Debt 2020
40 882 M - -
P/E ratio 2020
17,1x
Yield 2020
4,28%
Sales 2021
51 301 M - -
Net income 2021
12 506 M - -
Net Debt 2021
26 866 M - -
P/E ratio 2021
15,6x
Yield 2021
4,45%
Capitalization
196 B 196 B -
EV / Sales 2020
4,84x
EV / Sales 2021
4,35x
Nbr of Employees
88 300
Free-Float
59,1%
Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines. The Company manages its commercial operations through two business segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). IH focuses on developing and commercializing medicines...
Notations Surperformance© of Pfizer Inc.
Trading Rating : Investor Rating :
All news about PFIZER INC.
News in other languages on PFIZER INC.
Analyst Recommendations on PFIZER INC.
PFIZER INC. - 10/20
Close to new upside potential
BUY
Next crop of COVID-19 vaccine developers take more traditional route
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends PFIZER INC.
Short Term Mid-Term Long Term Trends Bearish Neutral Neutral
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
OUTPERFORM
Number of Analysts
19
Average target price
42,21 $
Last Close Price
35,48 $
Spread / Highest target
55,0%
Spread / Average Target
19,0%
Spread / Lowest Target
-1,35%
Please enable JavaScript in your browser's settings to use dynamic charts.
Canada
Deutschland
France
Schweiz (DE)
United Kingdom
Report
